On April 1, 2025, the Secretary of Commerce initiated, pursuant to President Trump’s directive, two new investigations under Section 232 of the Trade Expansion Act of 1962 (Section 232), one on imports of pharmaceuticals and pharmaceutical ingredients, and derivative products of those items (collectively, pharmaceuticals) and the other on imports of semiconductors, semiconductor manufacturing equipment (SME) and their derivative products (collectively, semiconductors)….
By: Polsinelli
By: Polsinelli
